{"id":"W2003014459","doi":"10.1093/annonc/mdt048.4","title":"A Phase 1B Study of Brivanib in Combination with 5FU/LV and FOLFIRI in Patients with Advanced or Metastatic Gastro-Intestinal Malignancies","year":2013,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Tolerability; FOLFIRI; Internal medicine; Nausea; Mucositis; Vomiting; Gastroenterology; Regimen; Neutropenia; Oncology; Irinotecan; Surgery; Colorectal cancer; Adverse effect; Cancer; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002172287,0.00168259,0.003263585,0.0007191641,0.0005287784,0.001537912,0.001347048,0.001526969,0.007003487],"category_scores_gemma":[0.001430034,0.001158895,0.002628953,0.0006823065,0.001183383,0.001566134,0.000483015,0.005393697,0.001794458],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001452713,"about_ca_system_score_gemma":0.002203976,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001713132,"about_ca_topic_score_gemma":0.00560288,"domain_scores_codex":[0.9993111,0.0003534364,0.00002687306,0.0001124289,0.00004336892,0.0001527742],"domain_scores_gemma":[0.99921,0.0001603462,0.0001383971,0.0000668712,0.00004841808,0.0003759828],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8595668,0.03920632,0.003319848,0.0008543945,0.002369227,0.0001165625,0.0002212871,0.002122008,0.01792772,0.0002767572,0.004889009,0.06912992],"study_design_scores_gemma":[0.7851328,0.2028436,0.006166595,0.00003770892,0.000865743,0.0001287767,0.0000614449,0.0007010763,0.001207061,0.0001513869,0.002669083,0.0000346231],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9847569,0.005723565,0.000633109,0.001493244,0.000445526,0.001684661,0.001762646,0.0002138446,0.003286613],"genre_scores_gemma":[0.9802569,0.004326529,0.002517341,0.001992204,0.0004143606,0.002192329,0.003724346,0.00009476901,0.004481127],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007003487,"threshold_uncertainty_score":0.02342898,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0492746070131608,"score_gpt":0.3593437677843544,"score_spread":0.3100691607711936,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}